Comments
Commented by Stefan Feulner on November 17th, 2020 | 09:58 CET
BYD, Upco International, Moderna: bet on the winners!
Who will win the race for the fastest and best vaccine against the Coronavirus? After the first test results, specific trends are emerging. It is clear now, driven by news, large fluctuations and thus high price gains are possible. The overall stock market seems not to care about this, just that a vaccine will be available soon, is enough. After a short correction, the trend goes south again. The market could see significantly higher prices next year.
Read
Commented by Carsten Mainitz on November 16th, 2020 | 10:15 CET
Adidas, RYU Apparel, Puma: Rising returns
It is not always high-tech shares or highly speculative investments with which an investor can generate high returns. Those investors who have patience and foresight have been able to look forward to a number of share price multiplications at many sporting goods manufacturers in recent years. There is no standard success formula for the participants such as Nike, Adidas, Under Armour or Puma. The developments have not been without their setbacks. Investors should pay attention to newcomers in the industry with innovative approaches.
Read
Commented by André Will-Laudien on November 16th, 2020 | 09:48 CET
Velocity Minerals, B2Gold, Delivery Hero: We take up the fight!
The news of a vaccine against Corona with a success rate of 90% caused markets to skyrocket since last Monday. While the Dow Jones and the S&P set 500 new records, gold plummeted by as much as USD 118 in one day. Gold's most significant daily drop in more than seven years also wiped out its breakout from a 3-month downward wedge last Friday.
As gold futures closed below USD 1,890 this week on the Comex, the strong sell-off below this support brings with it the possibility that the zone between USD 1,750 and USD 1,800 will be tested again before the correction of the safe-haven metal's large gains finds a significant bottom. The gold futures base of USD 1,800 has technically become a critical support level, an area that dates back to the bull market of 2008.
Read
Commented by Stefan Feulner on November 13th, 2020 | 13:13 CET
Varta, Royal Helium, Deutsche Telekom - Buy the future!
When it comes to the DAX, the first thing to do is to take a breather. After the brilliant Biden-BioNTech rally, the leading German index started to move south. And today, not only did companies listed on the DAX release encouraging quarterly figures but companies like Merck and Siemens, Deutsche Telekom, in particular, raised its forecast. Also, in the segments below, there were spectacular figures. After the setback in the markets, there are some buying opportunities here.
Read
Commented by Nico Popp on November 13th, 2020 | 12:48 CET
EXMceuticals, KWS Saat, Nokia: Talk about crashes and comebacks
When the EXMceuticals share was quoted above the 1 EUR mark last summer, the sky hung full of violins for cannabis investors. In North America, the active ingredient was largely liberalized, and in other regions of the world, too, it seemed that cannabis would soon become a medical substance like many others. But at least the hype has died down on the stock market. In the meantime, EXMceuticals shares are trading at just EUR 0.12. What has happened?
Read
Commented by André Will-Laudien on November 13th, 2020 | 12:40 CET
Pfizer, BioNTech, Desert Gold - inoculate portfolios with gold!
After only three days, disillusionment already! The winners of yesterday are the losers of today. Since Monday's vaccination rocket, the markets have been hanging around up there, looking to see if any more buyers have left the sickbed of the last bear market. Unfortunately, no, the case is rather that airlines are, on average, down 5% again and a battered TUI is looking for further state aid which pushes the price back towards 4 euros. The problematic week began as the Dow rose by 4% to a new record high, and yields on ten-year government bonds shot up by almost 17% in a single day as investors relinquished security. Oil prices rose by 8% as people now believe that the stalled economy is coming back to life.
Meanwhile, the US dollar index rose by about 60 basis points, while even some exotic currencies with higher beta jumped too. Of course, some gold and silver enthusiasts wonder if a vaccine is enough to kill both the Covid-19 virus and the bull market in precious metals as gold and silver lost between 5 and 9%. However, if you look at the markets today, the chances are that smart money, in particular, will start to buy the dips in the precious metals.
Read
Commented by André Will-Laudien on November 12th, 2020 | 11:33 CET
Barrick Gold, Palantir Technologies, Osino Resources: Take a deep breath!
Small clearance sale! On wild vaccine Monday, the price of gold fell nearly USD 100 but has so far held at the critical support level of USD 1,850 after Pfizer and BioNTech announced a potential vaccine against the COVID-19 virus. Many investors hold gold and silver (also beaten by 7%) as crisis protection. This can go wrong in the short term - but in the long term, it is exciting.
"The virus may disappear, but that doesn't mean that economic growth will turn around on a cent," said Ole Hansen, Head of Commodity Strategy at Saxo Bank. "A lot of damage has been done that cannot be easily repaired or will take a long time to fix". That's just the way it is - COVID-19 changes a lot of things, especially the risk mentality of people. The economies have to go in new directions in 2021/22.
Read
Commented by Stefan Feulner on November 12th, 2020 | 10:03 CET
Alibaba, Silver Viper, Saturn Oil & Gas, CureVac: You need to know!
High fluctuation margins are currently being observed on the market. Due to the shift into cyclical stocks, especially tech stocks like Amazon, Alibaba or the Companies benefiting enormously from the Corona pandemic, like ZOOM or TeamViewer, are falling. Here, after a first commute, there are good buying opportunities. Gold and silver stocks should also be added to the watch list. The uncertainty is certainly not over.
Read
Commented by Nico Popp on November 12th, 2020 | 09:23 CET
Newmont, SolGold, Anglo American: When does the takeover carousel turn?
Commodities have been an exciting asset class again for a few months now. Despite the pandemic and the economic setbacks, the prices of commodities such as industrial metals or oil developed positively. The gold sector also picked up significantly, thanks to the support programs of the states, and the measures of the central banks. As the large gold companies, in particular, have shrunk healthily in recent years and worked on their cost structures, the ruble is rolling. Commodity giant Newmont reported a free cash flow of USD 1.3 billion in the third quarter alone, and free funds are also bubbling up at Barrick Gold. In an ordinary world, such figures lead to takeover speculation. But the pandemic is making travel and detailed due diligence on commodity projects difficult.
Read
Commented by Nico Popp on November 11th, 2020 | 14:15 CET
Tesla, Defense Metals, HelloFresh: Who makes a 468% return?
When Tesla advertised its electric sports car around 10 years ago and let journalists drive the chic little vehicle around Germany, the Company was a highly speculative affair. The electric pioneers now have various vehicles on offer and are market leaders in their field. But that does not stop the share from making huge profits: The Tesla share climbed by almost 470% within the past twelve months.
Read